Not Medicare Enrolled

Dr. Daniel Traviesa, MD

Neurology · Lakeland, FL
Low-engagement
1600 LAKELAND HILLS BLVD, Lakeland, FL 33805
8636807300
In practice since 2006 (20 years)
NPI: 1679549422 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Traviesa from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Traviesa? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Traviesa

Dr. Daniel Traviesa is a neurology in Lakeland, FL, with 20 years in practice.

Between the years covered by Open Payments, Dr. Traviesa received a total of $13,434 from 57 pharmaceutical and/or device companies across 837 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Traviesa is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice$ $13,434 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$13,434
Total received (2018-2024)
Avg $1,919/year across 7 years
Top 23% in FL for neurology
57
Companies
837
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,133 (97.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$302 (2.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$21
2023
$67
2022
$34
2021
$796
2020
$2,765
2019
$4,412
2018
$5,339

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$1,070
Novartis Pharmaceuticals Corporation
$1,051
UCB, Inc.
$1,028
Teva Pharmaceuticals USA, Inc.
$1,011
GENZYME CORPORATION
$798
Avanir Pharmaceuticals, Inc.
$639
Allergan Inc.
$549
Sunovion Pharmaceuticals Inc.
$538
Supernus Pharmaceuticals, Inc.
$534
Allergan, Inc.
$465
EMD Serono, Inc.
$430
Adamas Pharmaceuticals, Inc.
$389
Biogen, Inc.
$366
Jazz Pharmaceuticals Inc.
$352
Eisai Inc.
$337
Acorda Therapeutics, Inc
$302
AbbVie, Inc.
$271
Biohaven Pharmaceuticals, Inc.
$266
CSL Behring
$234
Lilly USA, LLC
$204
ACADIA Pharmaceuticals Inc
$197
Harmony Biosciences LLC
$195
Lundbeck LLC
$182
AbbVie Inc.
$176
US WorldMeds, LLC
$155
Alexion Pharmaceuticals, Inc.
$139
Genentech USA, Inc.
$137
Grifols USA, LLC
$120
GE Healthcare
$111
EISAI INC.
$109
PORTOLA PHARMACEUTICALS, INC.
$102
TerSera Therapeutics LLC
$91
Penumbra, Inc.
$72
Impax Laboratories, Inc.
$72
Medtronic USA, Inc.
$70
Upsher-Smith Laboratories LLC
$66
Bayer HealthCare Pharmaceuticals Inc.
$61
AQUESTIVE THERAPEUTICS, INC.
$55
JAZZ PHARMACEUTICALS INC.
$51
LivaNova USA, Inc.
$48
OWP Pharmaceuticals, Inc.
$45
GE HEALTHCARE
$42
Boston Scientific Corporation
$32
Kyowa Kirin, Inc.
$32
E.R. Squibb & Sons, L.L.C.
$30
SK Life Science, Inc.
$25
Vertical Pharmaceuticals, LLC
$22
PORTOLA PHARMACEUTICALS, LLC
$20
GRT US Holding, Inc.
$20
Mallinckrodt Enterprises LLC
$18
Celgene Corporation
$17
Amneal Pharmaceuticals LLC
$16
Merz North America, Inc.
$15
Greenwich Biosciences, Inc.
$15
Janssen Pharmaceuticals, Inc
$14
Alnylam Pharmaceuticals Inc.
$14
Medtronic Vascular, Inc.
$13
Top 3 companies account for 23.4% of total payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AJOVY · AMPYRA · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · BOTOX · BOTOX THERAPEUTIC · Betaseron · Briviact · COPAXONE · DIVIGEL · Duopa · EMGALITY · Epidiolex · Fycompa · GILENYA · GOCOVRI · Gamunex-C · Hizentra · INBRIJA · KESIMPTA · KYNMOBI · LEMTRADA · LUMIZYME · Lamotrigine Starter Kit · MAYZENT · Mavenclad · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · OCREVUS · ONPATTRO · ONZETRA Xsail · OXTELLAR XR · POMPE - DISEASE · PRIALT · Penumbra Jet 7 · Penumbra System · Privigen · QUDEXY XR Topiramate Extended Release Capsules · Qutenza · RYTARY · Rebif · Reveal LINQ · SOLIRIS · SUNOSI · SYMPAZAN · SYNCHROMED · Soliris · Solitaire · Subvenite · TECFIDERA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · VNS Therapy · VRAYLAR · Vimpat · WATCHMAN · Wakix · XEOMIN · XYWAV · Xadago · Xyrem · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology in Lakeland?
Compare neurologys in the Lakeland area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
30
Per 100K population
3.9
County median income
$63,644
Nearest hospital
LAKELAND REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment— Not enrolledN/A
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Traviesa is a neurology, and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Traviesa receive payments from pharmaceutical companies?
Yes. Dr. Traviesa received a total of $13,434 from 57 companies across 837 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Traviesa) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →